Art therapy meets oncology: could mandala coloring boost cancer Patients' well-being?
NCT ID NCT07752667
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study tests whether a music-assisted mandala coloring activity can improve psychological well-being and quality of life in adults receiving their first chemotherapy treatment for cancer. Participants will color mandalas weekly for 8 weeks, guided by an instructional video, and their psychological adjustment and quality of life will be measured against baseline. The goal is to see if this simple, non-drug approach can help patients cope better with the side effects and emotional stress of chemotherapy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A behavioral intervention combining mandala coloring with music, performed weekly during chemotherapy.
- What this could lead to
- If effective, this simple, low-cost art therapy could become a supportive tool to help cancer patients cope better with chemotherapy, improving their emotional well-being and quality of life.
- What could go wrong
- This is a small early-stage trial, so results may not apply broadly. The benefit is uncertain, and the intervention is not a treatment for cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients who have been diagnosed with cancer, * aged 18 or over, * receiving chemotherapy for the first time, * able to hold a pen, * agreed to take part in the study Exclusion Criteria: * Decline to participate in the study or do not provide written informed consent. * Have physical conditions that would prevent participation in the mandala intervention (e.g., severe pain, severe nausea, or severe vomiting). * Have mental health conditions or cognitive impairment that limit their ability to communicate or participate in the intervention. * Experience fatigue primarily due to causes other than chemotherapy (e.g., severe anemia with hemoglobin \< 9 g/dL). * Are unable to hold or use a pen to complete the mandala activity.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cemil Ta
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a gentler blood thinner shield cancer patients from new clots?
- Can more phone calls after cancer surgery keep patients out of the hospital?
- Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
- Matching cancer survivors to the right level of support
- Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?